Clinical trial
Clinical, Instrumental, and Molecular (Circulating and Tissue microRNAs) Characterization of Patients With Cardiomyopathy to Identify Critical Patients With Severe Organ Failure to be Candidates for Cardiac Transplantation
NCT06813443 is registered in ClinicalTrials.gov with IRCCS Azienda Ospedaliero-Universitaria di Bologna as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Clinical, Instrumental, and Molecular (Circulating and Tissue microRNAs) Characterization of Patients With Cardiomyopathy to Identify Critical Patients With Severe Organ Failure to be Candidates for Cardiac Transplantation
- Lead sponsor
- IRCCS Azienda Ospedaliero-Universitaria di Bologna
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- February 13, 2023
- Completion date
- December 14, 2027
- Enrollment
- 700 (estimated)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
amyloidosis cardiac, arrhythmogenic cardiomyopathy, cardiac magnetic resonance imaging, cardiomyopathies, dilated cardiomyopathy, dystrophia myotonica, echocardiogram, electrocardiogram, fabry disease, glycogen storage disease, heart transplantation, hypertrophic cardiomyopathy (hcm), infiltrative cardiomyopathy, laminopathies, micro rna, mitochondrial cardiomyopathy, sudden cardiac death